D. Scott

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

N. Waugh, P. Hewitson, D. Scott, 2001, Health technology assessment.

Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system

R. Launois, K. Le Lay, M. Sidhu, 2007, The European Journal of Health Economics.

PCV66 THE VALUE OF MYOCARDIAL PERFUSION SCINTIGRAPHY (MPS) IN CORONARY ARTERY DISEASE (CAD):A REVIEW OF THE ECONOMIC LITERATURE SUBMITTED TO THE UK NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE)

L. Vale, M. G. Chambers, D. Scott, 2006 .

The value of myocardial perfusion scintigraphy (MPS) in coronary artery disease (CAD)

L. Vale, M. G. Chambers, D. Scott, 2006 .

Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review

N. Waugh, P. Hewitson, D. Scott, 2002, Thorax.